Silverleafe Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Silverleafe Capital Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,206	Closed	-$213K	–	58
2022 Q4	$213K	Buy	+1,206	New	+$208K	0.14%	52
2022 Q3	–	Sell	-1,201	Closed	-$213K	–	67
2022 Q2	$213K	Buy	1,201 +3	+0.3%	+$535	0.13%	57
2022 Q1	$212K	Sell	1,198 -16	-1%	-$2.72K	0.1%	65
2021 Q4	$208K	Sell	1,214 -551	-31%	-$90.2K	0.07%	83
2021 Q3	$285K	Sell	1,765 -492	-22%	-$83.9K	0.11%	68
2021 Q2	$372K	Hold	2,257	–	–	0.14%	69
2021 Q1	$371K	Buy	+2,257	New	+$365K	0.15%	73
2019 Q2	–	Sell	-2,314	Closed	-$323K	–	76
2019 Q1	$323K	Buy	2,314 +2	+0.1%	+$268	0.19%	49
2018 Q4	$298K	Buy	+2,312	New	+$323K	0.2%	49

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Silverleafe Capital Partners's JNJ Position: Q1 2023 in Review

Silverleafe Capital Partners sold out of Johnson & Johnson (JNJ) in Q1 2023, closing a stake of 1,206 shares — an estimated $213K sold.

Silverleafe Capital Partners first reported a position in JNJ in Q4 2018 and held it in 9 quarters. The position peaked at $372K in Q2 2021. 3,729 funds tracked by Wall St. Rank hold JNJ as of Q1 2023.

Silverleafe Capital Partners reported no remaining Johnson & Johnson position as of Q1 2023 after selling out during the quarter.
Silverleafe Capital Partners sold 1,206 Johnson & Johnson shares in Q1 2023, an estimated $213K.
Silverleafe Capital Partners first reported a position in Johnson & Johnson in Q4 2018 and held it in 9 quarters.
Silverleafe Capital Partners's Johnson & Johnson position peaked at $372K in Q2 2021.
3,729 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2023.

Based on Silverleafe Capital Partners's 13F filing for Q1 2023, filed 6 Apr 2023.